H-YMDDVVLGA-OH

Ref. 3D-PP49402

Informations sur le produit

• Nom: H-YMDDVVLGA-OH

Description

Peptide H-YMDDVVLGA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YMDDVVLGA-OH include the following: Effects of lamivudine on the hepatitis B virus specific CD8+ cytotoxic T lymphocyte responses via peptide-MHC tetrameric complexes assay TH Lee, YL Chuang, SL Tsai, YF Liaw - Letters in Peptide Science, 2001 - Springerhttps://link.springer.com/article/10.1023/A:1016245617290 Identification of novel hepatitis B virus therapeutic vaccine candidates derived from polymerase protein J Zheng, Z Xia, Y Xu, Z Ou, X Lin, S Jin, Y Liu - Aging (Albany , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202855/ In silico analysis of epitope-based vaccine candidates against hepatitis B virus polymerase protein J Zheng, X Lin, X Wang, L Zheng, S Lan, S Jin, Z Ou - Viruses, 2017 - mdpi.comhttps://www.mdpi.com/1999-4915/9/5/112 Resistance to lamivudine therapy: is there more than meets the eye? G Dusheiko, A Bertoletti - Gut, 2005 - gut.bmj.comhttps://gut.bmj.com/content/54/1/9.short High frequency of functional anti-YMDD and-mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for CL Lin, SL Tsai, TH Lee, RN Chien, SK Liao, YF Liaw - Gut, 2005 - gut.bmj.comhttps://gut.bmj.com/content/54/1/152.short Chronic diarrhoea after allogenic bone marrow transplantation B Radu, M Allez , JM Gornet, M Lemann, G Socie - Gut, 2005 - gut.bmj.comhttps://gut.bmj.com/content/54/1/161.extract

• Marque: Biosynth